Humacyte, Inc. (HUMA) Reports In-Line Q4 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/10/2026
- Wall St falls as tech losses, Middle East tensions deepen
- Oil prices jump after Trump threatens to hit Iran 'very hard'
- Oracle reports earnings today: Analysts say this metric could 'catalyze higher multiples'
- UBS sees generational semiconductor boom, highlights stock winners
- Has Tesla solved the self-driving puzzle? This analyst thinks so
- Hut 8 Mining Corp. (HUT) PT Raised to $55 at KBW As Management Delivers
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Micron to deliver 'another strong quarter', Goldman says
- Supermicro plans $7 billion financing to fund AI server orders
- UK's Ofcom requires tech firms to create crisis response plans
Humacyte Announces Fourth Quarter and Year End 2025 Financial Results and Provides Business Update
March 27, 2026 7:00 AM EDT- Total revenues from sales and research collaborations were $0.5 million for fourth quarter and $2.0 million for full year -Â
- Purchase commitment received for a minimum of $1.475 million for a clinical evaluation and outreach program in the Kingdom of Saudi Arabia -
- Submitted of a Marketing Authorization Application with the Israel Ministry of Health -
- U.S. Department of Defense authorized funding for procurement of bioengineered blood vessels -
- Major milestone upcoming:... More
